Evidence map›Paper›PMID 38693548›Full record

ArticleBMC health services research2024

Health system lessons from the global fund-supported procurement and supply chain investments in Zimbabwe: a mixed methods study.

Abaleng Lesego, Lawrence P O Were, Tsion Tsegaye, Rafiu Idris, Linden Morrison, Tatjana Peterson, Sheza Elhussein, Esther Antonio, Godfrey Magwindiri, Ivan Dumba and 5 more

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Abaleng LesegoAfrica Institute for Health Policy, P.O. Box 57266-00200, Nairobi, Kenya.
Lawrence P O WereAfrica Institute for Health Policy, P.O. Box 57266-00200, Nairobi, Kenya.
Tsion TsegayeAfrica Institute for Health Policy, P.O. Box 57266-00200, Nairobi, Kenya.
Rafiu IdrisGlobal Fund to Fight AIDs, Tuberculosis and Malaria, Geneva, Switzerland.
Linden MorrisonGlobal Fund to Fight AIDs, Tuberculosis and Malaria, Geneva, Switzerland.
Tatjana PetersonGlobal Fund to Fight AIDs, Tuberculosis and Malaria, Geneva, Switzerland.
Sheza ElhusseinGlobal Fund to Fight AIDs, Tuberculosis and Malaria, Geneva, Switzerland.
Esther Antonio, PricewaterhouseCoopers, Harare, Zimbabwe.
Godfrey Magwindiri, PricewaterhouseCoopers, Harare, Zimbabwe.
Ivan DumbaNational Pharmaceutical Company of Zimbabwe, Harare, Zimbabwe.
Cleyland MtambirwaNational Pharmaceutical Company of Zimbabwe, Harare, Zimbabwe.
Newman MadzikwaNational Pharmaceutical Company of Zimbabwe, Harare, Zimbabwe.
Raiva SimbiNational Pharmaceutical Company of Zimbabwe, Harare, Zimbabwe.
Misheck NdlovuMedicines Control Authority of Zimbabwe, Harare, Zimbabwe.
Tom AchokiAfrica Institute for Health Policy, P.O. Box 57266-00200, Nairobi, Kenya. tachoki@africahealthpolicy.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Global Fund partnered with the Zimbabwean government to provide end-to-end support to strengthen the procurement and supply chain within the health system. This was accomplished through a series of strategic investments that included infrastructure and fleet improvement, training of personnel, modern equipment acquisition and warehouse optimisation. This assessment sought to determine the effects of the project on the health system.

methodsThis study employed a mixed methods design combining quantitative and qualitative research methods. The quantitative part entailed a descriptive analysis of procurement and supply chain data from the Zimbabwe healthcare system covering 2018 - 2021. The qualitative part comprised key informant interviews using a structured interview guide. Informants included health system stakeholders privy to the Global Fund-supported initiatives in Zimbabwe. The data collected through the interviews were transcribed in full and subjected to thematic content analysis.

resultsApproximately 90% of public health facilities were covered by the procurement and distribution system. Timeliness of order fulfillment (within 90 days) at the facility level improved from an average of 42% to over 90% within the 4-year implementation period. Stockout rates for HIV drugs and test kits declined by 14% and 49% respectively. Population coverage for HIV treatment for both adults and children remained consistently high despite the increasing prevalence of people living with HIV. The value of expired commodities was reduced by 93% over the 4-year period. Majority of the system stakeholders interviewed agreed that support from Global Fund was instrumental in improving the country's procurement and supply chain capacity. Key areas include improved infrastructure and equipment, data and information systems, health workforce and financing. Many of the participants also cited the Global Fund-supported warehouse optimization as critical to improving inventory management practices.

conclusionIt is imperative for governments and donors keen to strengthen health systems to pay close attention to the procurement and distribution of medicines and health commodities. There is need to collaborate through joint planning and implementation to optimize the available resources. Organizational autonomy and sharing of best practices in management while strengthening accountability systems are fundamentally important in the efforts to build institutional capacity.

Indexed as

Delivery of Health CareEquipment and SuppliesHumansInternational CooperationQualitative ResearchZimbabweDevelopment assistance for healthDonor funded programsGlobal fundHealth systemsHealth systems strengtheningProcurement and supply chain management

Identifiers

PMID38693548
PMCPMC11061988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.